RedChip Companies
|
|
Weekly Newsletter
|
|
BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
|
BullFrog AI (Nasdaq: BFRG), a precision medicine company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced that the United States Patent and Trademark Office (USPTO) will, on August 1, 2023, issue U.S. Patent No. 11,712,435 protecting the Company’s novel prodrugs derived from mebendazole and their use in treating cancers and other diseases. The patented compounds exhibit improved solubility and oral bioavailability relative to the parent drug, thereby addressing a key difficulty encountered in evaluating the potential use of mebendazole for oncology indications.
For more information, visit www.bullfrogai.com
|
Genetic Technologies Issues Quarterly Update: Encouraging Growth for geneType Commercial Test Volume
Genetic Technologies (Nasdaq: GENE), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, provided its quarterly update for the period ended June 30, 2023. Commenting on the Company’s quarterly performance, CEO Simon Morriss said: “The June 2023 quarter provided some significant highlights. Growth in the commercial traction of the company’s geneType brand was experienced in both Australia and the U.S. This is being driven by a strengthened focus on sales and support, via our newly appointed Medical Science Liaison (MSL) team and our dedicated technical and customer support teams in the U.S. and Australia.”
|
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology
Unicycive Therapeutics (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, announced that the peer-reviewed international journal the American Journal of Nephrology has published positive results on the phosphate binding capacity for oxylanthanum carbonate (OLC).
|
|
|
American Resources Corporation’s ReElement Technologies Appoints Automotive and EV Industry Veteran Alex Hitzinger to Its Technical Advisory Board
American Resources’ (Nasdaq: AREC) subsidiary ReElement Technologies LLC, a leading provider of high performance refining capacity of battery and rare earth elements, today announced the appointment of automotive and EV industry veteran Alex Hitzinger to its Technical Advisory Board.
|
Everything Blockchain, Inc. Named a Finalist for CRN’s 2023 Tech Innovator Award
Everything Blockchain (OTC: EBZT), a technology company that is blending blockchain, DBMS and Zero Trust to deliver disruptive new ways to store, manage and protect data, today announced that CRN®, a brand of The Channel Company, has named EBI as a Finalist for the 2023 CRN Tech Innovator Awards. EBI is being recognized for BuildDB in the Data and Information Management category.
|
|
|
Small Stocks Big Money™ Podcasts
|
|
|
Upcoming Events |
|
|
|
|
| NASDAQ: STSS - Sharps Technology |
| 4:15pm Eastern |
| Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
|
| NASDAQ: ARDS - Aridis Pharmaceuticals |
| 4:15pm Eastern |
| Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
|
| NASDAQ: GENE - Genetic Technologies Limited |
| 4:15pm Eastern |
| Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
|
| NYSE American: ZOM - Zomedica |
| 4:15pm Eastern |
| Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians. |
|
|
|
|
|
| NASDAQ: DGLY - Digital Ally |
| 4:15pm Eastern |
| Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. |
|
|
|
|
|
| OTCQB: AMNI - American Noble Gas |
| 4:15pm Eastern |
| American Noble Gas Inc is active in the energy sector. It has conducted an environmental study and developed geological information from the reprocessing and additional evaluation of existing two-dimensional (2-D) seismic data in the Perlas and Tyra concession blocks. |
|
|
|
|
|
| NASDAQ: SXTP - Sixty Degrees Pharmaceuticals |
| 4:15pm Eastern |
| 60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| 4:15pm Eastern |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
Archive Events |
|
|
|
|
| NYSE American: GRFX - Graphex Group |
| Meeting Duration 47 minutes |
| Graphex Group is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases. |
|
|
|
|
|
| OTC: EBZT - Everything Blockchain |
| Meeting Duration 35 minutes |
| Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. |
|
|
|
|
|
| NASDAQ: SNGX - Soligenix |
| Meeting Duration 48 minutes |
| Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
|
| OTCQB: QYOUF - QYOU Media |
| Meeting Duration 46 minutes |
| QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
|
|
|
| NASDAQ: BIVI - BioVie |
| Meeting Duration 47 minutes |
| BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
|
| NASDAQ: SPI - SPI Energy |
| Meeting Duration 33 minutes |
| We are delighted to invite you to SPI Energy's Investor Day 2023, where you will have the chance to learn more about our strategic vision and growth plans and hear from key members of our leadership team. |
|
|
|
|
|
| NASDAQ: BFRG - BullFrog AI |
| Meeting Duration 31 minutes |
| BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| Meeting Duration 39 minutes |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
|
| NASDAQ: ARDS - Aridis Pharmaceuticals |
| Meeting Duration 48 minutes |
| Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
|
| NASDAQ: RVSN - Rail Vision |
| Meeting Duration 36 minutes |
| Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
|
| NYSE American: GNS - Genius Group |
| Meeting Duration 44 minutes |
| Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
|
| NASDAQ: STSS - Sharps Technology |
| Meeting Duration 48 minutes |
| Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
Lesson of the Week
Mitigate your risk in small-caps by buying a basket of stocks.
|
|
|
MidSouth Week in Review
The Fed raised interest rates by 0.25% to as much as 5.5%, the highest level in 22 years.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
|
© 2023 RedChip , All rights reserved
|
|
| |
|
|
